Burden of disease and costs of aneurysmal subarachnoid haemorrhage (aSAH) in the United Kingdom View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2010-04-27

AUTHORS

Oliver Rivero-Arias, Alastair Gray, Jane Wolstenholme

ABSTRACT

BACKGROUND: To estimate life years and quality-adjusted life years (QALYs) lost and the economic burden of aneurysmal subarachnoid haemorrhage (aSAH) in the United Kingdom including healthcare and non-healthcare costs from a societal perspective. METHODS: All UK residents in 2005 with aSAH (International Classification of Diseases 10th revision (ICD-10) code I60). Sex and age-specific abridged life tables were generated for a general population and aSAH cohorts. QALYs in each cohort were calculated adjusting the life tables with health-related quality of life (HRQL) data. Healthcare costs included hospital expenditure, cerebrovascular rehabilitation, primary care and community health and social services. Non-healthcare costs included informal care and productivity losses arising from morbidity and premature death. RESULTS: A total of 80,356 life years and 74,807 quality-adjusted life years were estimated to be lost due to aSAH in the UK in 2005. aSAH costs the National Health Service (NHS) pound168.2 million annually with hospital inpatient admissions accounting for 59%, community health and social services for 18%, aSAH-related operations for 15% and cerebrovascular rehabilitation for 6% of the total NHS estimated costs. The average per patient cost for the NHS was estimated to be pound23,294. The total economic burden (including informal care and using the human capital method to estimate production losses) of a SAH in the United Kingdom was estimated to be pound510 million annually. CONCLUSION: The economic and disease burden of aSAH in the United Kingdom is reported in this study. Decision-makers can use these results to complement other information when informing prevention policies in this field and to relate health care expenditures to disease categories. More... »

PAGES

6-6

References to SciGraph publications

  • 2006-09. Cost-of-Illness Studies in PHARMACOECONOMICS
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1186/1478-7547-8-6

    DOI

    http://dx.doi.org/10.1186/1478-7547-8-6

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1034370052

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/20423472


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/14", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Economics", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1402", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Applied Economics", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Health Economics Research Centre, Department of Public Health, University of Oxford, UK", 
              "id": "http://www.grid.ac/institutes/grid.4991.5", 
              "name": [
                "Health Economics Research Centre, Department of Public Health, University of Oxford, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Rivero-Arias", 
            "givenName": "Oliver", 
            "id": "sg:person.01076143105.13", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01076143105.13"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Health Economics Research Centre, Department of Public Health, University of Oxford, UK", 
              "id": "http://www.grid.ac/institutes/grid.4991.5", 
              "name": [
                "Health Economics Research Centre, Department of Public Health, University of Oxford, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Gray", 
            "givenName": "Alastair", 
            "id": "sg:person.01307325071.02", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01307325071.02"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Health Economics Research Centre, Department of Public Health, University of Oxford, UK", 
              "id": "http://www.grid.ac/institutes/grid.4991.5", 
              "name": [
                "Health Economics Research Centre, Department of Public Health, University of Oxford, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Wolstenholme", 
            "givenName": "Jane", 
            "id": "sg:person.0622337242.95", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0622337242.95"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.2165/00019053-200624090-00005", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1028237162", 
              "https://doi.org/10.2165/00019053-200624090-00005"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2010-04-27", 
        "datePublishedReg": "2010-04-27", 
        "description": "BACKGROUND: To estimate life years and quality-adjusted life years (QALYs) lost and the economic burden of aneurysmal subarachnoid haemorrhage (aSAH) in the United Kingdom including healthcare and non-healthcare costs from a societal perspective.\nMETHODS: All UK residents in 2005 with aSAH (International Classification of Diseases 10th revision (ICD-10) code I60). Sex and age-specific abridged life tables were generated for a general population and aSAH cohorts. QALYs in each cohort were calculated adjusting the life tables with health-related quality of life (HRQL) data. Healthcare costs included hospital expenditure, cerebrovascular rehabilitation, primary care and community health and social services. Non-healthcare costs included informal care and productivity losses arising from morbidity and premature death.\nRESULTS: A total of 80,356 life years and 74,807 quality-adjusted life years were estimated to be lost due to aSAH in the UK in 2005. aSAH costs the National Health Service (NHS) pound168.2 million annually with hospital inpatient admissions accounting for 59%, community health and social services for 18%, aSAH-related operations for 15% and cerebrovascular rehabilitation for 6% of the total NHS estimated costs. The average per patient cost for the NHS was estimated to be pound23,294. The total economic burden (including informal care and using the human capital method to estimate production losses) of a SAH in the United Kingdom was estimated to be pound510 million annually.\nCONCLUSION: The economic and disease burden of aSAH in the United Kingdom is reported in this study. Decision-makers can use these results to complement other information when informing prevention policies in this field and to relate health care expenditures to disease categories.", 
        "genre": "article", 
        "id": "sg:pub.10.1186/1478-7547-8-6", 
        "inLanguage": "en", 
        "isAccessibleForFree": true, 
        "isPartOf": [
          {
            "id": "sg:journal.1032048", 
            "issn": [
              "1478-7547"
            ], 
            "name": "Cost Effectiveness and Resource Allocation", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "1", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "8"
          }
        ], 
        "keywords": [
          "aneurysmal subarachnoid hemorrhage", 
          "quality-adjusted life years", 
          "non-healthcare costs", 
          "life years", 
          "subarachnoid hemorrhage", 
          "economic burden", 
          "hospital inpatient admissions", 
          "health-related quality", 
          "community health", 
          "burden of disease", 
          "total economic burden", 
          "health care expenditures", 
          "primary care", 
          "inpatient admissions", 
          "disease burden", 
          "patient costs", 
          "general population", 
          "healthcare costs", 
          "hospital expenditures", 
          "premature death", 
          "societal perspective", 
          "total NHS", 
          "care expenditures", 
          "life tables", 
          "hemorrhage", 
          "burden", 
          "cohort", 
          "informal care", 
          "productivity loss", 
          "prevention policies", 
          "care", 
          "United Kingdom", 
          "rehabilitation", 
          "social services", 
          "UK residents", 
          "years", 
          "health", 
          "NHS", 
          "life data", 
          "morbidity", 
          "admission", 
          "disease", 
          "death", 
          "SAH", 
          "sex", 
          "total", 
          "expenditure", 
          "healthcare", 
          "population", 
          "residents", 
          "study", 
          "Kingdom", 
          "services", 
          "loss", 
          "average", 
          "UK", 
          "categories", 
          "data", 
          "quality", 
          "cost", 
          "millions", 
          "results", 
          "information", 
          "table", 
          "operation", 
          "perspective", 
          "policy", 
          "field", 
          "aSAH cohorts", 
          "cerebrovascular rehabilitation", 
          "National Health Service (NHS) pound168.2 million", 
          "Health Service (NHS) pound168.2 million", 
          "Service (NHS) pound168.2 million", 
          "pound168.2 million"
        ], 
        "name": "Burden of disease and costs of aneurysmal subarachnoid haemorrhage (aSAH) in the United Kingdom", 
        "pagination": "6-6", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1034370052"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1186/1478-7547-8-6"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "20423472"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1186/1478-7547-8-6", 
          "https://app.dimensions.ai/details/publication/pub.1034370052"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2021-12-01T19:24", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20211201/entities/gbq_results/article/article_528.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1186/1478-7547-8-6"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/1478-7547-8-6'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/1478-7547-8-6'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/1478-7547-8-6'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/1478-7547-8-6'


     

    This table displays all metadata directly associated to this object as RDF triples.

    153 TRIPLES      22 PREDICATES      101 URIs      92 LITERALS      7 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1186/1478-7547-8-6 schema:about anzsrc-for:14
    2 anzsrc-for:1402
    3 schema:author Na8c5aed527f041e088958cc64b702d8b
    4 schema:citation sg:pub.10.2165/00019053-200624090-00005
    5 schema:datePublished 2010-04-27
    6 schema:datePublishedReg 2010-04-27
    7 schema:description BACKGROUND: To estimate life years and quality-adjusted life years (QALYs) lost and the economic burden of aneurysmal subarachnoid haemorrhage (aSAH) in the United Kingdom including healthcare and non-healthcare costs from a societal perspective. METHODS: All UK residents in 2005 with aSAH (International Classification of Diseases 10th revision (ICD-10) code I60). Sex and age-specific abridged life tables were generated for a general population and aSAH cohorts. QALYs in each cohort were calculated adjusting the life tables with health-related quality of life (HRQL) data. Healthcare costs included hospital expenditure, cerebrovascular rehabilitation, primary care and community health and social services. Non-healthcare costs included informal care and productivity losses arising from morbidity and premature death. RESULTS: A total of 80,356 life years and 74,807 quality-adjusted life years were estimated to be lost due to aSAH in the UK in 2005. aSAH costs the National Health Service (NHS) pound168.2 million annually with hospital inpatient admissions accounting for 59%, community health and social services for 18%, aSAH-related operations for 15% and cerebrovascular rehabilitation for 6% of the total NHS estimated costs. The average per patient cost for the NHS was estimated to be pound23,294. The total economic burden (including informal care and using the human capital method to estimate production losses) of a SAH in the United Kingdom was estimated to be pound510 million annually. CONCLUSION: The economic and disease burden of aSAH in the United Kingdom is reported in this study. Decision-makers can use these results to complement other information when informing prevention policies in this field and to relate health care expenditures to disease categories.
    8 schema:genre article
    9 schema:inLanguage en
    10 schema:isAccessibleForFree true
    11 schema:isPartOf N431e49b5d3a5432eb1ac70c3d32ebbb5
    12 Nff02187dac7e45a6bbaa41f40af8359c
    13 sg:journal.1032048
    14 schema:keywords Health Service (NHS) pound168.2 million
    15 Kingdom
    16 NHS
    17 National Health Service (NHS) pound168.2 million
    18 SAH
    19 Service (NHS) pound168.2 million
    20 UK
    21 UK residents
    22 United Kingdom
    23 aSAH cohorts
    24 admission
    25 aneurysmal subarachnoid hemorrhage
    26 average
    27 burden
    28 burden of disease
    29 care
    30 care expenditures
    31 categories
    32 cerebrovascular rehabilitation
    33 cohort
    34 community health
    35 cost
    36 data
    37 death
    38 disease
    39 disease burden
    40 economic burden
    41 expenditure
    42 field
    43 general population
    44 health
    45 health care expenditures
    46 health-related quality
    47 healthcare
    48 healthcare costs
    49 hemorrhage
    50 hospital expenditures
    51 hospital inpatient admissions
    52 informal care
    53 information
    54 inpatient admissions
    55 life data
    56 life tables
    57 life years
    58 loss
    59 millions
    60 morbidity
    61 non-healthcare costs
    62 operation
    63 patient costs
    64 perspective
    65 policy
    66 population
    67 pound168.2 million
    68 premature death
    69 prevention policies
    70 primary care
    71 productivity loss
    72 quality
    73 quality-adjusted life years
    74 rehabilitation
    75 residents
    76 results
    77 services
    78 sex
    79 social services
    80 societal perspective
    81 study
    82 subarachnoid hemorrhage
    83 table
    84 total
    85 total NHS
    86 total economic burden
    87 years
    88 schema:name Burden of disease and costs of aneurysmal subarachnoid haemorrhage (aSAH) in the United Kingdom
    89 schema:pagination 6-6
    90 schema:productId N1ec1ad2867dc4c67962603919589d4a4
    91 N6b5f6e7cdf2d4ef8a8b42829f987bc6a
    92 Na29fd825364841e4b2591bfb29654ac3
    93 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034370052
    94 https://doi.org/10.1186/1478-7547-8-6
    95 schema:sdDatePublished 2021-12-01T19:24
    96 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    97 schema:sdPublisher N3a882f0597dd42aca3cb43d1e1d473c5
    98 schema:url https://doi.org/10.1186/1478-7547-8-6
    99 sgo:license sg:explorer/license/
    100 sgo:sdDataset articles
    101 rdf:type schema:ScholarlyArticle
    102 N04521c1076894e3ba440b956ea01a3af rdf:first sg:person.0622337242.95
    103 rdf:rest rdf:nil
    104 N0c6360ed03d540a184e74c0e7a6e78cb rdf:first sg:person.01307325071.02
    105 rdf:rest N04521c1076894e3ba440b956ea01a3af
    106 N1ec1ad2867dc4c67962603919589d4a4 schema:name dimensions_id
    107 schema:value pub.1034370052
    108 rdf:type schema:PropertyValue
    109 N3a882f0597dd42aca3cb43d1e1d473c5 schema:name Springer Nature - SN SciGraph project
    110 rdf:type schema:Organization
    111 N431e49b5d3a5432eb1ac70c3d32ebbb5 schema:volumeNumber 8
    112 rdf:type schema:PublicationVolume
    113 N6b5f6e7cdf2d4ef8a8b42829f987bc6a schema:name pubmed_id
    114 schema:value 20423472
    115 rdf:type schema:PropertyValue
    116 Na29fd825364841e4b2591bfb29654ac3 schema:name doi
    117 schema:value 10.1186/1478-7547-8-6
    118 rdf:type schema:PropertyValue
    119 Na8c5aed527f041e088958cc64b702d8b rdf:first sg:person.01076143105.13
    120 rdf:rest N0c6360ed03d540a184e74c0e7a6e78cb
    121 Nff02187dac7e45a6bbaa41f40af8359c schema:issueNumber 1
    122 rdf:type schema:PublicationIssue
    123 anzsrc-for:14 schema:inDefinedTermSet anzsrc-for:
    124 schema:name Economics
    125 rdf:type schema:DefinedTerm
    126 anzsrc-for:1402 schema:inDefinedTermSet anzsrc-for:
    127 schema:name Applied Economics
    128 rdf:type schema:DefinedTerm
    129 sg:journal.1032048 schema:issn 1478-7547
    130 schema:name Cost Effectiveness and Resource Allocation
    131 schema:publisher Springer Nature
    132 rdf:type schema:Periodical
    133 sg:person.01076143105.13 schema:affiliation grid-institutes:grid.4991.5
    134 schema:familyName Rivero-Arias
    135 schema:givenName Oliver
    136 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01076143105.13
    137 rdf:type schema:Person
    138 sg:person.01307325071.02 schema:affiliation grid-institutes:grid.4991.5
    139 schema:familyName Gray
    140 schema:givenName Alastair
    141 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01307325071.02
    142 rdf:type schema:Person
    143 sg:person.0622337242.95 schema:affiliation grid-institutes:grid.4991.5
    144 schema:familyName Wolstenholme
    145 schema:givenName Jane
    146 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0622337242.95
    147 rdf:type schema:Person
    148 sg:pub.10.2165/00019053-200624090-00005 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028237162
    149 https://doi.org/10.2165/00019053-200624090-00005
    150 rdf:type schema:CreativeWork
    151 grid-institutes:grid.4991.5 schema:alternateName Health Economics Research Centre, Department of Public Health, University of Oxford, UK
    152 schema:name Health Economics Research Centre, Department of Public Health, University of Oxford, UK
    153 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...